Parkinson’s disease is a serious brain condition that gets worse over time. It causes problems with movement, such as shaking, muscle stiffness, and trouble with balance.
As the disease progresses, it becomes harder for people to walk, talk, and do everyday tasks.
Now, scientists from Queen Mary University of London have discovered a possible connection between Parkinson’s disease and certain medications used to treat seizures, known as antiepileptic drugs. These drugs help control unusual electrical activity in the brain and are commonly given to people with epilepsy.
To explore this possible link, the researchers looked at medical data from 1,433 people with Parkinson’s disease and compared them to 8,598 people without the condition. They focused on the patients’ prescriptions and studied which antiepileptic drugs they had taken. These included carbamazepine, lamotrigine, levetiracetam, and sodium valproate.
What they found was concerning. People who had taken antiepileptic drugs had a higher chance of developing Parkinson’s disease. The risk increased depending on how many prescriptions they had received.
In other words, the more often someone took these drugs, the higher their risk appeared to be. Also, those who used more than one type of antiepileptic drug had an even greater risk.
This is the first study to look at a wide range of seizure medications and their possible connection to Parkinson’s disease. The findings are important because they may influence how doctors choose and manage medications for people who need long-term seizure treatment.
Even though this research raises important concerns, the scientists say more studies are needed. They want to understand exactly how these medications might affect the brain and why they could increase the risk of Parkinson’s disease. Figuring this out could help lead to new ways to prevent or treat this condition, which currently has no cure.
It’s important to remember that antiepileptic drugs are life-saving for many people. They play a key role in preventing seizures and managing epilepsy. Patients should not stop taking their medicine without talking to their doctor first. Any changes in treatment should always be made under medical guidance.
This study, led by Daniel Belete and published in the journal JAMA Neurology, is an important step forward in learning more about what causes Parkinson’s disease. It reminds us how important research is in finding out which factors might increase the risk of developing this disease.
Doctors may need to be more cautious when prescribing these medications, especially for long-term use. At the same time, patients and families should stay informed and talk openly with their healthcare team about the risks and benefits of all treatments.
As researchers continue to learn more, this knowledge could help improve care and possibly reduce the chances of developing Parkinson’s disease in the future.
If you care about Parkinson’s disease, please read studies about how to improve walking in people with Parkinson’s disease and Scientists find causes of Parkinson’s and Lewy body dementia.
If you care about Parkinson’s disease, please read studies These common drugs may increase risk of Parkinson’s disease and Researchers find an important cause of Parkinson’s disease.
Copyright © 2025 Knowridge Science Report. All rights reserved.
